{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:40Z","timestamp":1791319840790,"version":"4.3.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:13:56Z","timestamp":1788390836000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cImpact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease after Letermovir Prophylaxis during the First 100 Days after Cord Blood Transplantation\u201d"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-8526","authenticated-orcid":false,"given":"Shun-ichi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-7857","authenticated-orcid":false,"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.08.018_bib0001","article-title":"Impact of acute graft-versus-host disease and delayed hematopoietic recovery on the incidence and clinical burden of late cytomegalovirus reactivation and disease after letermovir prophylaxis during the first 100 days after cord blood transplantation","author":"Okada","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.018_bib0002","doi-asserted-by":"crossref","first-page":"ofaf233","DOI":"10.1093\/ofid\/ofaf233","article-title":"The changing impact of human cytomegalovirus serology and infection on patient outcome after allogeneic hematopoietic stem cell transplantation: an Italian prospective multicenter survey in the era of letermovir prophylaxis","volume":"12","author":"Girmenia","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jtct.2026.08.018_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106220","article-title":"Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study","volume":"89","author":"Putz","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.jtct.2026.08.018_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2026.05.010","article-title":"Bidirectional associations between bacteraemia and cytomegalovirus infection after allogeneic haematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy Transplant Complications Working Group","author":"Kimura","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jtct.2026.08.018_bib0005","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/bloodadvances.2020001984","article-title":"Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.018_bib0006","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1182\/bloodadvances.2020003277","article-title":"Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation","volume":"4","author":"Camargo","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.018_bib0007","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2026.08.018_bib0008","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.018_bib0009","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1182\/blood.2021014255","article-title":"Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant","volume":"139","author":"Miltiadous","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.08.018_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2020009396","article-title":"Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation","volume":"138","author":"Zamora","year":"2021","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:54Z","timestamp":1791316734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"alternative-id":["S2666636726006238"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.018","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cImpact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease after Letermovir Prophylaxis during the First 100 Days after Cord Blood Transplantation\u201d","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.046","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}